Trials / Conditions / Ann Arbor Stage II Grade 2 Non-Contiguous Follicular Lymphoma
Ann Arbor Stage II Grade 2 Non-Contiguous Follicular Lymphoma
3 registered clinical trials studyying Ann Arbor Stage II Grade 2 Non-Contiguous Follicular Lymphoma.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Terminated | Rituximab With or Without Yttrium Y-90 Ibritumomab Tiuxetan in Treating Patients With Untreated Follicular Lym NCT02320292 | Mayo Clinic | Phase 3 |
| Active Not Recruiting | Rituximab, Lenalidomide, and Ibrutinib in Treating Patients With Previously Untreated Stage II-IV Follicular L NCT01829568 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Lenalidomide and Rituximab in Treating Patients With Previously Untreated Stage II, Stage III, or Stage IV Fol NCT01145495 | National Cancer Institute (NCI) | Phase 2 |